WINTON MATTHEW (COO) received a stock award from INOZYME PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/3/2024ACC: 0000950170-24-112694
+1.71K
Net shares
Net buyer
$7.6K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.71K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.71K
Price / share
$4.45
Trade value
$7.61K
% of position
53.6%
9/30/2024
3.19K→4.90K
Total
Net shares
+1.71K
Net value
$7.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2024 | A · Award | +1.71K | $4.45 | $7.61K | 53.6% | 3.19K | 4.90K |
| Total | +1.71K | $7.61K | ||||||
Derivative Transactions0
No derivative transactions reported